Nabriva Therapeutics AG
Biotechnology
Healthcare
NBRV
2.68 M shares
NASDAQ US
traded
31 Jul 2023
listed
yes
open
1.45
52 week high
3.82
high
1.90
52 week low
1.29
previous Close
1.42
P/E ratio
market cap
5.57 M
div yield
0
net incoming
-22.78 M
0.00 %
net profit margin
-218.20 %
-218.00 %
operating incoming
-22.33 M
0.00 %
net change in cash
-2.23 M
0.00 %
cash on hand
12.41 M
0.00 %
cost of revenue
16.35 M
0.00 %
top